Celiac disease presents unique challenges worldwide, and Argentina is no exception. As part of the Celiac Disease Foundation’s commitment to advancing global education and research, we actively support initiatives that…
Continue ReadingThe ILLUMINATE-101 Study is a phase 2 clinical research study evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingFor those living with celiac disease, every meal comes with a question: Is this truly safe to eat? While the gluten-free diet is the only available treatment, researchers are working…
Continue ReadingThe recent FDA clearance of the GlutenID genetic test has sparked discussion about its role in celiac disease screening. Celiac disease has a strong genetic component, and screening is generally recommended for…
Continue ReadingCeliac Disease Foundation Showcases Research and Advocacy at AOECS 2024 Reinforcing our commitment to advancing celiac disease research, education, and advocacy on…
Continue ReadingDear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...